Clinical Outcomes and Predictors of ST-Elevation Versus Non-ST-Elevation Myocardial Infarction with Non-Obstructive

Bin Xu1, Fuad A Abdu2, Lu Liu2

  • 1Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China; Medical College of Soochow University, Suzhou, China.

Insights

Myocardial infarction with nonobstructive coronary arteries (MINOCA) patients with ST-segment elevation (STE) and non-ST-segment elevation (NSTE) have similar 1-year outcomes, but different predictors for major adverse cardiovascular events.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Myocardial infarction with nonobstructive coronary arteries (MINOCA) presents challenges in understanding prognosis.
  • MINOCA is categorized into ST-segment elevation (STE) and non-ST-segment elevation (NSTE) types.
  • Clinical outcomes and predictors for STE-MINOCA and NSTE-MINOCA are not well-defined.

Purpose of the Study:

  • To compare the clinical outcomes of patients with STE-MINOCA and NSTE-MINOCA.
  • To identify predictors of major adverse cardiovascular events (MACE) in both STE-MINOCA and NSTE-MINOCA populations.

Main Methods:

  • A cohort of 265 MINOCA patients (102 STE, 163 NSTE) was analyzed.
  • Clinical profiles, prognoses, and predictors of MACE were assessed.
  • 1-year follow-up data was collected for all participants.

Main Results:

  • NSTE-MINOCA patients were older, more frequently female, and had higher rates of atrial fibrillation and NT-proBNP.
  • STE-MINOCA patients had higher rates of smoking history and diastolic blood pressure.
  • No significant differences in 1-year mortality or MACE rates were observed between STE-MINOCA and NSTE-MINOCA groups.

Conclusions:

  • Despite differing clinical profiles, STE-MINOCA and NSTE-MINOCA patients exhibit similar 1-year cardiovascular outcomes.
  • Predictive factors for MACE differ significantly between STE-MINOCA and NSTE-MINOCA groups.
  • Age, low total cholesterol, hypertension, and smoking history predict MACE in NSTE-MINOCA.
  • Reduced ejection fraction and diabetes mellitus predict MACE in STE-MINOCA.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
277
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
514
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
123
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
186
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
163
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
222